Remove FDA Remove Governance Remove Presentation
article thumbnail

A Brief Quantum Medicine Policy Guide

Bill of Health

Quantum-driven healthcare innovations present quantum-specific regulatory challenges, discussed in more detail below. The EU AI Act , proposed EU AI Liability Directive , and laws under the European Strategy for Data , such as the Data Governance Act , may also play roles. The regulatory landscape in the U.S.

FDA 182
article thumbnail

‘Care Anywhere’ is the new normal, according to industry report

Healthcare It News

Lastly, artificial intelligence (AI) gains significance and undergoes stronger scrutiny procedures in the US with more than a hundred new AI and machine learning (ML) based device approvals by the FDA. Enterprise Taxonomy: Operations Strategic Planning Digital Health Emerging Technologies Business Organizational Governance Technology.

COVID-19 264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

‘Care Anywhere’ is the new normal, according to new industry report

Healthcare It News

Lastly, artificial intelligence (AI) gains significance and undergoes stronger scrutiny procedures in the US with more than a hundred new AI and machine learning (ML) based device approvals by the FDA. Enterprise Taxonomy: Operations Strategic Planning Digital Health Emerging Technologies Business Organizational Governance Technology.

COVID-19 246
article thumbnail

What Counts as a Psychedelic?

Bill of Health

Besides grants for “psychedelic” research, the FDA just released draft guidance on considerations for psychedelic clinical investigations with an ambiguous definition of what is considered to be a “psychedelic.” When we discuss FDA clinical trials , we’re talking big money , so clarity matters here. cocaine ?).

FDA 193
article thumbnail

Psychedelic Lobbying and Regulatory Capture

Bill of Health

Stigler argued that the government’s main “resource” is the “power to coerce,” and therefore a rational interest group would seek to convince the government to use its coercive power for the group’s own benefit. But the most pertinent lobbying is currently working to shape the FDA’s guidelines for psychedelic therapy.

FDA 140
article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. government. government substantially de-risking the vaccine development process.

article thumbnail

A Brief Quantum Medicine Policy Guide

Bill of Health

Quantum-driven healthcare innovations present quantum-specific regulatory challenges, discussed in more detail below. The EU AI Act , proposed EU AI Liability Directive , and laws under the European Strategy for Data , such as the Data Governance Act , may also play roles. The regulatory landscape in the U.S.

FDA 130